Asia Pacific Body Fluid Collection And Diagnostics Market Size & Outlook
Asia Pacific body fluid collection and diagnostics market, 2018-2030 (US$M)
Related Markets
Asia Pacific body fluid collection and diagnostics market highlights
- The Asia Pacific body fluid collection and diagnostics market generated a revenue of USD 5,768.6 million in 2021.
- The market is expected to grow at a CAGR of 8.9% from 2022 to 2030.
- In terms of segment, blood was the largest revenue generating sample type in 2021.
- Blood is the most lucrative sample type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2022 to 2030.
Asia Pacific data book summary
| Market revenue in 2021 | USD 5,768.6 million |
| Market revenue in 2030 | USD 12,440.6 million |
| Growth rate | 8.9% (CAGR from 2021 to 2030) |
| Largest segment | Blood |
| Fastest growing segment | Blood |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Blood, Saliva, Urine, Cerebrospinal Fluid |
| Key market players worldwide | Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Illumina Inc, Guardant Health Inc, Qiagen NV, Johnson & Johnson, Labcorp Holdings Inc, Biocept Inc, Roche, MDxHealth SA |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.5% of the global body fluid collection and diagnostics market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 12,440.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Body Fluid Collection And Diagnostics Market Scope
Body Fluid Collection And Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific body fluid collection and diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to body fluid collection and diagnostics market will help companies and investors design strategic landscapes.
Blood was the largest segment with a revenue share of 74.96% in 2021. Horizon Databook has segmented the Asia Pacific body fluid collection and diagnostics market based on blood, saliva, urine, cerebrospinal fluid covering the revenue growth of each sub-segment from 2018 to 2030.
- Asia Pacific Body Fluid Collection And Diagnostics Sample Type Outlook (Revenue, USD Million, 2018-2030)
- Blood
- Saliva
- Urine
- Cerebrospinal Fluid
- Asia Pacific Body Fluid Collection And Diagnostics Product Outlook (Revenue, USD Million, 2018-2030)
- Tests/Services
- Kits & Consumables
- Instruments
- Asia Pacific Body Fluid Collection And Diagnostics Technology Outlook (Revenue, USD Million, 2018-2030)
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescence in situ hybridization (FISH)
- Others
- Asia Pacific Body Fluid Collection And Diagnostics Application Outlook (Revenue, USD Million, 2018-2030)
- Prognostics & Screening
- Diagnostics & Monitoring
- Therapeutic Decision Making
Reasons to subscribe to Asia Pacific body fluid collection and diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific body fluid collection and diagnostics market databook
-
Our clientele includes a mix of body fluid collection and diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific body fluid collection and diagnostics market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific body fluid collection and diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific body fluid collection diagnostics market report size, by country, 2018-2030 (US$M)
Asia Pacific Body Fluid Collection And Diagnostics Market Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
